| Announce Date | 11/11/2025 |
| EPS Normalized Actual | $-0.04 (Beat by $0.01) |
| EPS GAAP Actual | $-0.04 (Beat by $0.01) |
| Revenue Actual | $0.015156B |
| Revenue Surprise | Beat by $15.156M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.03 |
| EPS GAAP Estimate | $-0.03 |
| Revenue Estimate | $0.015748B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2028 | -0.03 | -99.33 | -0.03011524 | -0.02988476 | 1 |
| Mar 2027 | 0.02 | 149 | 0.0194797 | 0.0205203 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0368 | 0.0132 | 0.015156B | 93.32% | 1.18M |
| FQ2 2025 (Jun 2025) | -0.04 | -0.04 | 0.014994B | 12.24% | 0.09M |
| FQ1 2025 (Mar 2025) | -0.06 | 0 | 0.014097B | 16.95% | -1.93M |
| FQ4 2024 (Dec 2024) | -0.0645 | -0.0145 | 0.01271B | 17.84% | -1.13M |
| FQ3 2024 (Sep 2024) | -0.06 | -1.60141 | 0.001012B | 100% | -17.26M |
| FQ2 2024 (Jun 2024) | -0.0576 | -0.0176 | 0.013159B | 100% | 0.41M |
| FQ1 2023 (Mar 2023) | 0 | 0 | 0.008843B | 7.08% | 8.84M |
| FQ1 2024 (Mar 2024) | 0 | 0.05 | 0.011707B | 24.46% | 0.71M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.03
Consensus Revenue Estimates
0.015748B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | -0.02 | -- | -0.02037693 | -0.01962307 | 1 |
| FQ4 2026 (Dec 2026) | -0.03 | -- | -0.03056539 | -0.02943461 | 1 |
| FQ3 2026 (Sep 2026) | -0.03 | -22.67 | -0.03056539 | -0.02943461 | 1 |
| FQ2 2026 (Jun 2026) | -0.02 | -100 | -0.02037693 | -0.01962307 | 1 |
| FQ1 2026 (Mar 2026) | -0.03 | -100 | -0.03056539 | -0.02943461 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2026 (Sep 2026) | 0.02B | 10.44 | 0.02B | 0.02B | 1 |
| FQ2 2026 (Jun 2026) | 0.02B | 15.25 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.02B | 10.48 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.05 | -0.0368 | 0.0132 | -35.87% |
| FQ2 2025 (Jun 2025) | 0 | -0.04 | -0.04 | 100% |
| FQ1 2025 (Mar 2025) | -0.06 | -0.06 | 0 | 0% |
| FQ4 2024 (Dec 2024) | -0.05 | -0.0645 | -0.0145 | 22.48% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.06 | -1.60141 | 2669.02% |
| FQ2 2024 (Jun 2024) | -0.04 | -0.0576 | -0.0176 | 30.56% |
| FQ1 2023 (Mar 2023) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | -0.05 | 0 | 0.05 | INF% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $0.02B | $1.18M | 7.76% |
| FQ2 2025 (Jun 2025) | $0.01B | $0.01B | $0.09M | 0.63% |
| FQ1 2025 (Mar 2025) | $0.02B | $0.01B | $-1.93M | -13.71% |
| FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $-1.13M | -8.93% |
| FQ3 2024 (Sep 2024) | $0.02B | $0B | $-17.26M | -1705.68% |
| FQ2 2024 (Jun 2024) | $0.01B | $0.01B | $0.41M | 3.11% |
| FQ1 2023 (Mar 2023) | $0B | $0.01B | $8.84M | 100% |
| FQ1 2024 (Mar 2024) | $0.01B | $0.01B | $0.71M | 6.04% |